Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microencapsulated hepatocytes for bioartificial liver support.

Z H Cai1, Z Q Shi, G M O'Shea

  • 1University of Toronto, Department of Physiology, Ontario, Canada.

Artificial Organs
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A study on the efficacy and safety profile of transjugular intrahepatic portosystemic shunt received elderly patients with liver cirrhosis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same author

[Comparison of the efficacy of isoperistaltic and antiperistaltic anastomosis in totally laparoscopic right hemicolectomy: a post-hoc analysis based on a national multicenter snapshot study].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2025
Same author

[Current status of interventional therapy for hepatic encephalopathy associated with spontaneous portosystemic shunts].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2025
Same author

[Analysis on the current status and characteristic of clinical trials for oral diseases in China].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2025
Same author

[Research progress on the interaction between valve endothelial cells and interstitial cells in calcific aortic valve disease].

Zhonghua xin xue guan bing za zhi·2024
Same author

[Risk factors for intrahepatic venovenous shunt in patients with cirrhosis and its impact on hepatic venous pressure gradient].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2024

Encapsulated rat hepatocytes in alginate-polylysine membranes served as a viable liver support system. This bioartificial liver successfully replaced damaged liver function and improved survival rates in rats with acute liver failure.

Area of Science:

  • Hepatology
  • Biomaterials Science
  • Regenerative Medicine

Background:

  • Fulminant hepatic failure (FHF) presents a critical unmet medical need due to limited donor organs for transplantation.
  • Hepatocyte transplantation offers a potential alternative to whole-organ liver grafts.
  • Developing a robust and functional bioartificial liver (BAL) support system is crucial for managing liver failure.

Purpose of the Study:

  • To develop and evaluate an encapsulated hepatocyte system as a potential liver support therapy.
  • To assess the viability, function, and therapeutic efficacy of encapsulated hepatocytes in a preclinical model of liver failure.

Main Methods:

  • Isolation of primary rat hepatocytes via collagenase perfusion.
  • Encapsulation of hepatocytes within alginate-polylysine membranes to create a bioartificial liver device.

Related Experiment Videos

  • In vitro culture to assess cell viability and protein synthesis.
  • In vivo transplantation into rats with galactosamine-induced FHF to evaluate therapeutic effects.

    • Main Results:

    • Encapsulated hepatocytes maintained viability and protein synthesis for up to 3 weeks in culture.
    • Allografts of encapsulated hepatocytes demonstrated the ability to replace damaged liver function.
    • Transplantation significantly reduced mortality rates in rats experiencing galactosamine-induced FHF.

    Conclusions:

    • Alginate-polylysine encapsulation provides a protective environment for hepatocytes, maintaining their viability and function.
    • Encapsulated hepatocytes represent a promising therapeutic strategy for acute liver failure.
    • This bioartificial liver system shows potential for clinical translation in liver support.